J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kishore, K.
Right arrow Articles by Shriniwas,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kishore, K.
Right arrow Articles by Shriniwas,
Agricola
Right arrow Articles by Kishore, K.
Right arrow Articles by Shriniwas,

The Journal of Medical Microbiology, Vol 37, Issue 6 364-367, Copyright © 1992 by Society for General Microbiology

JOURNAL ARTICLE

Serum antibodies to verotoxin-producing Escherichia coli (VTEC) strains in patients with haemolytic uraemic syndrome

K. Kishore, A. Rattan, A. Bagga, R. N. Srivastava, N. M. Nath and
Department of Microbiology, All India Institute of Medical Sciences, New Delhi.

Serological evidence of infection with verotoxin-producing Escherichia coli (VTEC) was sought in 28 patients suffering from haemolytic uraemic syndrome (HUS) and 25 age- and sex-matched controls. ELISA was used to detect anti-lipopolysaccharide (LPS) antibodies to E. coli strains O157, O111, O26 and NCTC 10418, a non-VTEC strain, and Shigella dysenteriae O1. Sera from 19 of the HUS patients but from none of the 25 controls had significant antibody levels to the verotoxin-producing bacteria. Sera from 13 patients reacted with only one LPS of the four verotoxin-producing bacteria; sera from six reacted with more than one LPS antigen but not with LPS of E. coli NCTC 10418. Paired sera taken 2-3 weeks apart were obtained from 20 HUS patients; 14 of these had high levels of antibody in the acute phase sample. Analysis of antibody levels in the convalescent sera showed that one patient had an increase, one was unchanged and 12 patients had a decrease in antibody to the verotoxin-producing bacteria.


This article has been cited by other articles:


Home page
 PediatricsHome page
T. A. McCarthy, N. L. Barrett, J. L. Hadler, B. Salsbury, R. T. Howard, D. W. Dingman, C. D. Brinkman, W. F. Bibb, and M. L. Cartter
Hemolytic-Uremic Syndrome and Escherichia coli O121 at a Lake in Connecticut, 1999
Pediatrics, October 1, 2001; 108(4): e59 - 59.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. L. SIEGLER, T. J. PYSHER, V. L. TESH, and F. B. TAYLOR JR.
Response to Single and Divided Doses of Shiga Toxin-1 in a Primate Model of Hemolytic Uremic Syndrome
J. Am. Soc. Nephrol., July 1, 2001; 12(7): 1458 - 1467.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
C. G. CURRIE, K. McCALLUM, and I. R. POXTON
Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli O157 in health and disease
J. Med. Microbiol., April 1, 2001; 50(4): 345 - 354.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 1992 Society for General Microbiology.